Clinical trial
Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
NCT01570036
Study timeline
Study start (actual)2013-05-21Date precision: day
Registry last updated2020-12-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
Sponsors & collaborators
Mapped research locations
BaltimoreMaryland, United States3Washington D.C.District of Columbia, United States2PlantationFlorida, United States2New YorkNew York, United States1HoustonTexas, United States1PhiladelphiaPennsylvania, United States1MiamiFlorida, United States1San AntonioTexas, United States1SeattleWashington, United States1TampaFlorida, United States1PortlandOregon, United States1IndianapolisIndiana, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01570036 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.